Medtronic Leaves Guidance Unchanged As Q3 Earnings Beat Expectations

Medtronic noted that U.S. revenue gained 4% from last year to $4.106 billion, and represented 56% of its total sales. Non-U.S. developed market revenue gained 6% to $2.193 billion, representing 30% of its total.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.